Wickert L, Watzka M, Bolkenius U, Bidlingmaier F, Ludwig M
Department of Clinical Biochemistry, University of Bonn, Germany.
Eur J Endocrinol. 1998 Jun;138(6):702-4. doi: 10.1530/eje.0.1380702.
The mineralocorticoid receptor (MR), a member of the steroid receptor family, acts as a transcription factor and mediates both aldosterone and cortisol effects. Aldosterone specificity in some tissues results from the inactivation of competing cortisol into cortisone by 11beta-hydroxysteroid dehydrogenase. In other tissues MR and the glucocorticoid receptor show overlapping physiological effects or may act together by forming a heterodimer. An additional MR splice variant (MR+4) has been found in different mRNA samples from rat tissues and human white blood cells, thereby implying additional modes of MR-regulated effects. We therefore looked for the presence of these two MR-mRNA isoforms in human classical aldosterone target tissues and various other tissues. MR-mRNA was found in all samples investigated, thereby showing the expression of MR to be more abundant than has been observed thus far. In addition, the MR+4-mRNA variant was also found in all the tissues examined.
盐皮质激素受体(MR)是类固醇受体家族的成员,作为一种转录因子,介导醛固酮和皮质醇的作用。某些组织中醛固酮的特异性是由于11β-羟基类固醇脱氢酶将竞争性皮质醇失活转化为可的松所致。在其他组织中,MR和糖皮质激素受体表现出重叠的生理效应,或者可能通过形成异二聚体共同发挥作用。在大鼠组织和人类白细胞的不同mRNA样本中发现了一种额外的MR剪接变体(MR+4),这意味着MR调节效应存在其他模式。因此,我们在人类经典醛固酮靶组织和其他各种组织中寻找这两种MR-mRNA亚型的存在。在所研究的所有样本中均发现了MR-mRNA,这表明MR的表达比迄今为止观察到的更为丰富。此外,在所有检测的组织中也发现了MR+4-mRNA变体。